{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:58:24Z","timestamp":1781528304206,"version":"3.54.1"},"reference-count":33,"publisher":"Informa UK Limited","issue":"7","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2026,6,7]]},"DOI":"10.1080\/10428194.2026.2658135","type":"journal-article","created":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T16:04:35Z","timestamp":1776614675000},"page":"1450-1457","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["From JAK to CALR: redefining therapeutic targets in myeloproliferative neoplasms"],"prefix":"10.1080","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4632-1073","authenticated-orcid":false,"given":"Anushri","family":"Soni","sequence":"first","affiliation":[{"name":"Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine","place":["Bronx, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Verma","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Montefiore Medical Center, Albert Einstein College of Medicine","place":["Bronx, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Goel","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Montefiore Medical Center, Albert Einstein College of Medicine","place":["Bronx, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,4,19]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-03-460154"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051113"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)71142-9"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030270"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1311347"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1312542"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.17713"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-539098"},{"key":"e_1_3_2_10_1","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Myeloproliferative neoplasms (Version 1.2026); 2026. https:\/\/www.nccn.org."},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110557"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2021.106770"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-022-03335-7"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-10777-w"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-023-01634-5"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0564-z"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.70048"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-141159"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202152904"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024024373"},{"key":"e_1_3_2_21_1","first-page":"12","volume-title":"Annual Meeting of the European Hematology Association","author":"Mascarenhas J","year":"2025","unstructured":"Mascarenhas J, Ali H, Yacoub A, et\u00a0al. INCA33989 is a novel, first in class, mutant calreticulin-specific monoclonal antibody that demonstrates safety and efficacy in patients with essential thrombocythemia. In Annual Meeting of the European Hematology Association, Milano, Italy, June; 2025. p. 12\u201315."},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2025-1024"},{"key":"e_1_3_2_23_1","unstructured":"Psaila B. ; 2025). INCA035784 a novel equipotent T cell\u2013redirecting antibody for patients with myeloproliferative neoplasms carrying different types of calreticulin mutations.\u00a0Oral presentation S212 at EHA2025."},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-173430"},{"issue":"1","key":"e_1_3_2_25_1","first-page":"256","article-title":"Discovery of first-in-class precision antibody drug conjugates targeting mutant calreticulin for the treatment of myeloproliferative neoplasms","volume":"9","author":"Fultang N","year":"2025","unstructured":"Fultang N, Schwab A, Chandratre S, et\u00a0al. Discovery of first-in-class precision antibody drug conjugates targeting mutant calreticulin for the treatment of myeloproliferative neoplasms. Hemasphere. 2025;9(Suppl. S1):256\u2013257.","journal-title":"Hemasphere"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-204953"},{"key":"e_1_3_2_27_1","article-title":"Development and evaluation of a novel CAR-T cell therapy against calreticulin mutant neoplasms","volume":"216","author":"Rampotas A","year":"2024","unstructured":"Rampotas A, Gannon I, Wong Z, et\u00a0al. Development and evaluation of a novel CAR-T cell therapy against calreticulin mutant neoplasms. European Hematology Association Congress Abstracts. EHA Library. Abstract. 2024;S216:248\u2013249.","journal-title":"European Hematology Association Congress Abstracts. EHA Library. Abstract"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.214"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.637420"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1240678"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-1356"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005491"},{"key":"e_1_3_2_33_1","first-page":"12","volume-title":"Annual Meeting of the European Hematology Association","author":"Otoukesh S","year":"2025","unstructured":"Otoukesh S, Psaila B, Kuykendall A, et\u00a0al. ; 2025. A phase 1 study of VAC85135, a neoantigen vaccine regimen targeting calreticulin and JAK2 mutations, in combination with ipilimumab (IPI) in patients (PTS) with myeloproliferative neoplasms (MPNS). In\u00a0Annual Meeting of the European Hematology Association, Milano, Italy\u00a0(12\u201315."},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2025-2051"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2026.2658135","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:43:57Z","timestamp":1781527437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2026.2658135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,19]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,6,7]]}},"alternative-id":["10.1080\/10428194.2026.2658135"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2026.2658135","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-11-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}